Mark Christianson
Business Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC); Market Development Director at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $55K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 2SEC | NMTCNEUROONE MEDICAL TECHNOLOGIES Corp | Sell | 10,00020,692 held (−33%) | $3.18 | $32K | -64.8% |
| Apr 1SEC | NMTCNEUROONE MEDICAL TECHNOLOGIES Corp | Sell | 15,363198,920 held (−7%) | $0.74 | $11K | +51.4% |
| Mar 16SEC | NMTCNEUROONE MEDICAL TECHNOLOGIES Corp | Sell | 817214,383 held (−0%) | $0.80 | $654 | +40.0% |
| Mar 16SEC | NMTCNEUROONE MEDICAL TECHNOLOGIES Corp | Sell | 100214,283 held (−0%) | $0.80 | $80 | +40.0% |
| Mar 12SEC | NMTCNEUROONE MEDICAL TECHNOLOGIES Corp | Sell | 11,611217,309 held (−5%) | $0.80 | $9K | +40.0% |
| Mar 12SEC | NMTCNEUROONE MEDICAL TECHNOLOGIES Corp | Sell | 2,109215,200 held (−1%) | $0.80 | $2K | +40.0% |
- Sell
Market Development Director Mark Christianson sold $32K of NMTC at $3.18 — cuts the stake by 33%.